Pulmonary Adverse Events of Anti-Tumor Necrosis Factor-α Antibody Therapy
To access this article, please choose from the options below
This work was supported in part by the American Lung Association, and the American Lung Association of Metropolitan Chicago (G.M.M.), National Institute of Diabetes & Digestive & Kidney Diseases (E.A.M.), National Institute on Aging and Veterans Administration (I.R.).
PII: S0002-9343(06)00153-7
doi:10.1016/j.amjmed.2006.01.015
© 2006 Elsevier Inc. All rights reserved.

